0
0
0
0
1
2
3
$0
Is Baxter International solid or fragile? The Finex Financial Health Scanner reads BAX's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $11.2B |
|---|---|
| Net income | -$957.0M |
| Operating margin | -2.7% |
| Net margin | -8.5% |
| Cash and investments | $2.0B |
| Total debt | $9.5B |
| Free cash flow | $1.2B |
| Revenue growth (1 year) | 5.7% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.